Article Text
Featured editorial
C-reactive protein for risk assessment in coronary artery disease
Statistics from Altmetric.com
Footnotes
Funding ND has received research grants from Pfizer, Servier and The Medicines Company. He has also received fees for speaking in industry-sponsored symposia and/or consulting for Astra-Zeneca, BMS, Boehringer-Ingelheim, GSK, Lilly, Menarini, MSD-Schering, Novartis, Novo, Pfizer, Sanofi-Aventis, Servier, The Medicines Company.
Competing interests None.
Provenance and peer review Not commissioned; not externally peer reviewed.